BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine and Infant Mortality in Africa

Clinical trial NCT07005726 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07005726
Sponsor: Bandim Health Project
Status: ENROLLING_BY_INVITATION
Phase: Phase 4
Study type: INTERVENTIONAL

Infant Morbidity Infant Mortality Non-Specific Effects of Vaccines BCG

Start date: 2025-05-09
Primary completion: 2030-05-01
Enrollment: 6000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.